Ftorafurisanantimetabolitepyrimidineanalogthatexhibitsanticancerchemotherapeuticactivity.Ftorafurisaprodrugof5-fluorouracilthatinhibitsthymidylatesynthase,preventingthymidinesynthesis.Ftorafuristypicallyclinicallyco-admiNISTeredwithotherchemotherapeuticstodecreaseitsperipheralcytotoxicity.
| CasNo. | 17902-23-7 |
|---|---|
| Purity | ≥98% |
| Formula | C8H9FN2O3 |
| FormulaWt. | 200.17 |
| ChemicalName | 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione |
| IUPACName | 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione |
| Synonym | Tegafur;Citofur;Furafluor;5-Fluoro-1-(tetrahydro-2-furyl)uracil |
| MeltingPoint | 164-169°C |
| Solubility | Solubleinhotwater,ethanol,methanol,orDMSO. |
| Appearance | WhiteCrystalPowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | F7657MSDSPDF |
|---|---|
| InfoSheet | F7657InfoSheetPDF |
FukushimaM.AntitumoractivityandfunctionofS-1,aneworaltegafur-basedformulation.GanToKagakuRyoho.2006Jun;33Suppl1:19-26.PMID:16897968.
LongleyDB,HarkinDP,JohnstonPG.5-fluorouracil:mechanismsofactionandclinicalstrategies.NatRevCancer.2003May;3(5):330-8.PMID:12724731.
TanakaF,FukuseT,WadaH,etal.Thehistory,mechanismandclinicaluseoforal5-fluorouracilderivativechemotherapeuticagents.CurrPharmBiotechnol.2000Sep;1(2):137-64.PMID:11467334.
